SUMMARY Malignant lymphocytic lymphoma rarely involves the eye. In two patients we found ocular signs and symptoms as the initial presentation of systemic disease. In the first patient periorbital swelling and ptosis of one year's duration ultimately proved to be the result of malignant lymphoma. After resolution of swelling and ptosis with chemotherapy, the patient returned with diffuse iris involvement and uveitis with a hypopyon. In the second patient an acute change of refractive error proved to be the result of a lymphomatous deposit in the choroid. In both instances common symptoms were the initial manifestations of a diffuse malignant disease.
Although malignant lymphocytic lymphoma involves the orbit in 2-3% of cases, intraocular lesions are very uncommon. In any event infiltration of ocular or orbital tissues is usually a late manifestation of the disease. We describe here two patients with ocular and adnexal involvement by malignant lymphocytic lymphoma in whom these ocular signs were the first indication of systemic disease. For Eye Institute. Ophthalmic examination revealed visual acuity to be 20/80 OU with symmetrical periorbital soft tissue swelling, exophthalmos, and restricted extraocular movements (Fig. 1 ). Abnormal tissue densities were palpable beneath the skin of the lids bilaterally. Fundus examination revealed choroidal folds (Fig. 2) . Ultrasound examination showed low reflective, regularly structured, multilobulated lesions involving orbital soft tissues, lid, extraocular muscles, and lacrimal glands. A general medical examination showed nothing abnormal. The patient had no lymphadenopathy or enlargement of liver or spleen. CT scan at this time showed extensive infiltration of both orbits by soft tissue masses of various sizes (Fig. 3) . A biopsy of the nodular tissue by anterior orbitotomy revealed a fibrous, salmon coloured tissue which on histological section was composed of poorly differentiated lymphoblasts (Fig. 4) . Further staging by oncologists demonstrated splenic enlargement on abdominal CT scan and bone marrow involvement consistent with poorly differen- tiated lymphocytic lymphoma. As the patient denied fever, night sweats, or weight loss, she was staged IV A. Chemotherapy was begun on 30 September with cyclophosphamide 750 mg/m2 by mouth, doxorubicin hydrochloride 50 mg/m2, vincristine 1-5 mg/m2, and prednisone 100 mg. The cyclophosphamide, doxorubicin, and vincristine were given on day 1. Prednisone was given on five consecutive days following initiation of therapy. This regimen was repeated approximately every three weeks. By 12 October the patient showed dramatic improvement, with resolution of periorbital swelling and diplopia (Fig. 5 ). Subsequently she was given six additional treatments over five months, with continued improvement in her condition.
In On repeat examination a week later she no longer noted the pain and redness. Her physical signs had resolved, and the steroids were gradually tapered. Over the next several months she had two episodes of uveitis which responded to steroids and cycloplegia. In June 1985 the uveitis again returned, but this time it did not respond to treatment. The oncologist who had been following her up found recurrent lymphoma of the abdomen and chest. By 17 July 1985 her vision had dropped to 20/80, with a large hypopyon and 4+ cell and flare with dramatic nodular iris infiltrates (Fig. 6) Fig. 7 ). There was some leakage from the foveal lesion in the left eye. The angiogram was interpreted as compatible with metastatic disease.
Biopsy of the oesophageal lesions by endoscopy revealed a mixed lymphocytic lymphoma with small and large cells. Further examination ultimately revealed diffuse involvement of the oesophagus, bone marrow, and submental, cervical, and retroperitoneal lymph nodes, so the disease was staged as grade 4. Chemotherapy was initiated with vincristine, cyclophosphamide, and dexamethasone.
By 10 May 1984 the refractive error in the left eye had reverted to its pre-existing state, with resolution of the serous detachment. The two peripheral lesions noted in the superotemporal quadrants in both eyes had also regressed, leaving only a scattered pigment epithelial reaction over the previous areas of involvement. Similarly, the oesophageal and lymph node lesions cleared after seven courses of chemotherapy.
Discussion
This report concerns two patients with diffuse lymphocytic lymphoma whose initial symptoms led them to consult an ophthalmologist. The first patient presented with chronic periorbital swelling and ptosis (which had been increasing) for one year. Subsequently the patient returned with diffuse iris infiltration and uveitis which initially responded to steroids, and then progressed despite radiation therapy and several courses of chemotherapy. In the second patient a change in refraction secondary to lymphomatous choroidal deposits brought him to an ophthalmologist, who initiated the examination that led to the diagnosis of a malignant lymphocytic lymphoma. Neither patient noted night sweats, fever, weight loss, or any other systemic manifestations of the disease.
Orbital infiltrates are not uncommon in malignant lymphoma, occurring in 2-4% of patients, but it is usually a late complication and may be difficult to diagnose.'-3 The conjunctiva is the most frequent tissue involved followed by the lid, orbit, and lacrimal gland. Most lesions occur unilaterally, involving right and left sides equally frequently. Periorbital swelling is the commonest presenting symptom followed by proptosis, ptosis, pain, and poor or blurred vision. Abnormal tissue can be palpated in over 90% of orbital metastases. Most lesions are present for 8 to 10 months prior to diagnosis.4
In contrast, intraocular involvement in lymphoma is uncommon, except in cases of reticulum cell sarcoma or large cell histiocytic lymphoma. Reticulum cell sarcoma usually presents as a chronic uveitis which is not responsive to steroids in a patient in the sixth or In summary, these patients illustrate the need for complete examination in the face of non-specific or negative findings, so that a correct diagnosis can be made. The ophthalmologist must be aware that potentially malignant lesions may present solely with common ocular symptoms and may be the harbingers of systemic disease. 
